What is Hurdle?
Hurdle operates as a healthcare venture studio, dedicated to creating groundbreaking solutions for the most pressing health challenges. The company employs a founder-led approach, drawing on the expertise of a diverse group of healthcare professionals to redefine healthcare through research-driven initiatives. Hurdle's strategic focus spans various healthcare domains, including primary, preventative, and geriatric care, emphasizing a provider-focused and expert-backed strategy to advance human health.
How much funding has Hurdle raised?
Hurdle has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2021): $5M with participation from Seae Ventures, F-Prime, and Veracode Inc
Key Investors in Hurdle
Seae Ventures
Seae Ventures is an investor in the healthcare sector, likely focusing on early-stage companies with innovative solutions.
F-Prime
F-Prime is a venture capital firm with a strong presence in healthcare and life sciences, investing in companies at various stages of development.
Veracode Inc
Veracode Inc is an investor that may be exploring opportunities within the healthcare technology space, potentially related to data security or compliance.
What's next for Hurdle?
With its recent major strategic investment, Hurdle is poised to accelerate its mission of advancing human health. The substantial capital infusion, part of its $5M total funding, will likely fuel the development and launch of new impactful healthcare ventures. This enterprise-level backing suggests a focus on scaling operations, expanding research capabilities, and potentially forging new strategic partnerships to further its objective of redefining healthcare delivery and outcomes.
See full Hurdle company page
